Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria.
Department of Clinical Chemistry, University of Liege, Liege, Belgium.
Clin Chem. 2023 Nov 2;69(11):1307-1316. doi: 10.1093/clinchem/hvad151.
Determining serum 25-hydroxyvitamin D [25(OH)D], 24,25-dihydroxyvitamin D [24,25(OH)2D] and the vitamin D metabolite ratio (VMR) allows the identification of individuals with a low vitamin D metabolite profile. Here, we evaluated if such a functional approach provides superior diagnostic information to serum 25(OH)D alone.
25(OH)D, 24,25(OH)2D, and the VMR were determined in participants of the DESIRE (Desirable Vitamin D Concentrations, n = 2010) and the LURIC (Ludwigshafen Risk and Cardiovascular Health, n = 2456) studies. A low vitamin D metabolite profile (vitamin D insufficiency) was defined by a 24,25(OH)2D concentration <1.2 ng/mL (<3 nmol/L) and a VMR <4%. Parathyroid hormone (PTH) and bone turnover markers were measured in both cohorts, whereas 10-year mortality data was recorded in LURIC only.
The median age in DESIRE and LURIC was 43.3 and 63.8 years, respectively. Median 25(OH)D concentrations were 27.2 ng/mL (68.0 nmol/L) and 15.5 ng/mL (38.8 nmol/L), respectively. Serum 25(OH)D deficiency, defined as <20.2 ng/mL (<50 nmol/L), was present in 483 (24.0%) and 1701 (69.3%) participants of DESIRE and LURIC, respectively. In contrast, only 77 (3.8%) and 521 (21.2%) participants had a low vitamin D metabolite profile. Regardless of the serum 25(OH)D concentration, a low vitamin D metabolite profile was associated with a significantly higher PTH, accelerated bone metabolism, and higher all-cause mortality than an unremarkable vitamin D metabolite profile.
The personalized assessment of vitamin D status using a functional approach better identifies patients with accelerated bone metabolism and increased mortality than the use of a fixed 25(OH)D cutoff of 20 ng/mL (50 nmol/L).
测定血清 25-羟维生素 D [25(OH)D]、24,25-二羟维生素 D [24,25(OH)2D] 和维生素 D 代谢物比值(VMR)可以识别维生素 D 代谢物水平较低的个体。在这里,我们评估了这种功能性方法是否比单独使用血清 25(OH)D 提供更好的诊断信息。
在 DESIRE(理想维生素 D 浓度,n=2010)和 LURIC(路德维希港风险和心血管健康,n=2456)研究的参与者中测定 25(OH)D、24,25(OH)2D 和 VMR。低维生素 D 代谢物谱(维生素 D 不足)定义为 24,25(OH)2D 浓度<1.2ng/mL(<3nmol/L)和 VMR<4%。在两个队列中均测量甲状旁腺激素(PTH)和骨转换标志物,而仅在 LURIC 中记录 10 年死亡率数据。
DESIRE 和 LURIC 的中位年龄分别为 43.3 岁和 63.8 岁。中位 25(OH)D 浓度分别为 27.2ng/mL(68.0nmol/L)和 15.5ng/mL(38.8nmol/L)。血清 25(OH)D 缺乏症(定义为<20.2ng/mL(<50nmol/L))分别见于 DESIRE 和 LURIC 的 483(24.0%)和 1701(69.3%)名参与者中。相比之下,仅有 77(3.8%)和 521(21.2%)名参与者存在低维生素 D 代谢物谱。无论血清 25(OH)D 浓度如何,低维生素 D 代谢物谱与更高的 PTH、加速的骨代谢和更高的全因死亡率相关,而不是与正常的维生素 D 代谢物谱相关。
使用功能性方法个性化评估维生素 D 状态比使用固定的 25(OH)D 截止值 20ng/mL(50nmol/L)能更好地识别加速骨代谢和增加死亡率的患者。